Oncology Intelligence Digest • November 13, 2026

Oncology Intelligence Digest November 13, 2026 On November 10, the FDA approved Merck KGaA’s pimicotinib (Pimjetmi) for tenosynovial…

Pro Hub Membership Required

You must be a Pro Hub member to access this content.

Join Now

Already a member? Log in here